Cytomegalovirus in bone marrow cells correlates with cytomegalovirus in peripheral blood leukocytes

Journal of Clinical Microbiology

Volumn 52, Issue 6, 2014, Pages 2183-2185

  Capobianchi, Angela ^a   Iori, Anna Paola ^a   Micozzi, Alessandra ^a   Torelli, Giovanni Fernando ^a   Testi, Anna Maria ^a   Girmenia, Corrado ^a   Santilli, Stefania ^a   Barberi, Walter ^a   Antonelli, Guido ^b   Foà, Robin ^a   Gentile, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; MATRIX PROTEIN; PHOSPHOPROTEIN; PP67 PROTEIN, HUMAN CYTOMEGALOVIRUS; VIRUS DNA;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; BONE MARROW CELL; BONE MARROW SUPPRESSION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DONOR; GRAFT RECIPIENT; HUMAN; LEUKOCYTE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS DETECTION; VIRUS LOAD; ADOLESCENT; ADULT; BLOOD; CHILD; FEMALE; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PHOSPHOPROTEINS; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 84901675880     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00702-14     Document Type: Article

References (16)

1. Minton EJ, Tysoe C, Sinclair JH, Sissons JG. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017-4021 (Pubitemid 24177428)
2. Meyer-König U, Hufert FT, von Laer DM. 1997. Infection of blood and bone marrow cells with the human cytomegalovirus in vivo. Leuk. Lymphoma 25:445-454 (Pubitemid 27361889)
3. Movassagh M, Gozlan J, Senechal B, Baillou C, Petit JC, Lemoine FM. 1996. Direct infection of CD34 progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood 88:1277-1283 (Pubitemid 26276802)
4. von Laer D, Meyer-Koenig U, Serr A, Finke J, Kanz L, Fauser AA, Neumann-Haefelin D, Brugger W, Hufert FT. 1995. Detection of cytomegalovirus DNA in CD34 cells from blood and bone marrow. Blood 86:4086-4090
5. Nakamae H, Storer B, Sandmaier BM, Maloney DG, Davis C, Corey L, Storb R, Boeckh M. 2011. Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs. Haematologica 96:1838-1845. http://dx.doi.org/10.3324/ haematol.2011.044966
6. Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T. 1997. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 90:2097-2102 (Pubitemid 27377326)
7. Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M, Smith TF, Paya CV. 2002. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 73:968-973 (Pubitemid 34252365)
8. Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. 2000. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032-2036. http://dx.doi.org/10.1016/S0140-6736(00)02350-3 (Pubitemid 30339241)
9. Boeckh M, Hoy C, Torok-Storb B. 1998. Occult cytomegalovirus infection of marrow stroma. Clin. Infect. Dis. 26:209-210. http://dx.doi.org/10.1086/517022 (Pubitemid 28068195)
10. Gentile G, Picardi A, Capobianchi A, Spagnoli A, Cudillo L, Dentamaro T, Tendas A, Cupelli L, Ciotti M, Volpi A, Amadori S, Martino P, de Fabritiis P. 2006. A prospective study comparing quantitative cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation. BMC Infect. Dis. 6:167-177. http://dx.doi.org/10.1186/1471-2334-6-167
11. Green ML, Leisenring W, Stachel D, Pergam SA, Sandmaier BM, Wald A, Corey L, Boeckh M. 2012. Efficacy of a viral load-based, risk adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 18:1687-1699. http://dx.doi.org/10.1016/j.bbmt.2012.05.015
12. Cho BS, Yahng SA, Kim JH, Yoon JH, Shin SH, Lee SE, Choi SM, Lee DG, Eom KS, Park G, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW. 2013. Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy. Ann. Hematol. 92:497-504. http://dx.doi.org/10.1007/ s00277-012-1632-x.
13. Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A. 2011. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays monitoring therapeutic response. Transplantation 91:231-236. http://dx.doi.org/10.1097/TP. 0b013e3181ff8719
14. Capobianchi A, Iori AP, Micozzi A, Torelli GF, Girmenia C, Santilli S, Antonelli G, Foà R, Gentile G. 2012. Abstract V-393. Abstr. 52nd Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC), San Francisco, CA.
15. Carrigan DR, Knox KK. 1994. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6 associated bone marrow suppression in bone marrow transplant patients. Blood 84:3307-3310 (Pubitemid 24352891)
16. Randolph-Habecker J, Iwata M, Torok-Storb B. 2002. Cytomegalovirus mediated myelosuppression. J. Clin. Virol. 25(Suppl 2):S51-S56. (Pubitemid 35287191)